Video proceedings from the first in a series of 6 integrated
symposia held at the 2019 ONS Annual Congress. Featuring
perspectives from Ms Jessica Mitchell, Dr Eileen M O’Reilly, Dr
Philip A Philip and Ms Amanda Wagner.
Introduction 0m0s
Program overview: Dr Love
Colorectal Cancer (CRC) (5:43)
Case (Ms Wagner): A man in his mid-70s with metastatic
appendiceal carcinoma who received third-line TAS-102 after disease
progression on FOLFIRI/bevacizumab and FOLFOX/bevacizumab
(8:11)
Case (Ms Mitchell): A man in his early 40s with MSI-high
metastatic CRC who experienced a dramatic response to pembrolizumab
(29:59)
Hepatocellular Carcinoma
(HCC) (36:14)
Case (Ms Wagner): A man in his mid-40s with metastatic HCC who
developed hand-foot syndrome while receiving sorafenib (38:21)
Case (Ms Mitchell): A woman in her mid-60s with metastatic HCC
who had a good response to nivolumab but developed arthralgias
(58:07)
Pancreatic
Cancer (1:04:33)
Case (Ms Mitchell): A woman in her mid-70s with locally
advanced pancreatic cancer who received neoadjuvant FOLFIRINOX
(1:04:47)
Case (Ms Wagner): A man in his mid-60s with metastatic
pancreatic cancer who received nab paclitaxel/gemcitabine and
nal-IRI (1:12:13)
Gastroesophageal Cancers (1:20:20)
Case (Ms Wagner): A man in his early 70s with metastatic
esophageal adenocarcinoma who received FOLFOX followed by
paclitaxel/ramucirumab upon disease progression (1:20:43)
Case (Ms Mitchell): A woman in her early 60s with metastatic
gastric cancer who experienced an excellent response to
pembrolizumab but developed autoimmune hypothyroidism
(1:24:02)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.